<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="int-interactant" /><meta name="keywords" content="" /><title>Cimetidine: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="41001i744.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="41001i744.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=41001i744.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="41001.htm">Appendix 1 Interactions</a> &gt; <a href="53178.htm">List of drug interactions</a> &gt; <a href="41001i741.htm">Ulcer-healing Drugs</a> &gt; <a href="41001i743.htm">Histamine H<sub>2</sub>-antagonists</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="41001i743.htm" title="Previous: Histamine H2-antagonists">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="41001i745.htm" title="Next: Famotidine">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_41001i744">Cimetidine</h1><div id="pC" class="jN"><p class="int-specific-drug-name"><b>Cimetidine</b>
          has the following interaction information:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody><tr><td><a href="41001i118.htm" name="_118">Amiodarone</a></td><td> cimetidine increases plasma concentration of amiodarone </td><td>Amiodarone has a long half-life; there is a potential for drug interactions to occur for several weeks (or even months) after treatment with it has been stopped</td></tr><tr><td><a href="41001i242.htm" name="_242">Amitriptyline</a></td><td> cimetidine inhibits metabolism of amitriptyline (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i241.htm" name="_241">Antidepressants, Tricyclic</a></td><td> cimetidine possibly increases plasma concentration of tricyclics </td><td></td></tr><tr><td><a href="41001i363.htm" name="_363">Antipsychotics</a></td><td> cimetidine possibly enhances effects of antipsychotics </td><td>Increased risk of toxicity with myelosuppressive drugs</td></tr><tr><td><a href="41001i937.htm" name="_937">Artemether with Lumefantrine</a></td><td class="cBV"><b>avoidance of  cimetidine advised by manufacturer of artemether/lumefantrine </b></td><td></td></tr><tr><td><a href="41001i405.htm" name="_405">Benzodiazepines</a></td><td> cimetidine inhibits metabolism of benzodiazepines (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i466.htm" name="_466">Calcium-channel Blockers</a></td><td> cimetidine possibly inhibits metabolism of calcium-channel blockers (increased plasma concentration)</td><td>Dihydropyridine calcium-channel blockers include amlodipine, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine, and nimodipine</td></tr><tr><td><a href="41001i277.htm" name="_277">Carbamazepine</a></td><td class="cBV"><b> cimetidine inhibits metabolism of carbamazepine (increased plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i1123.htm" name="_1123">Carmustine</a></td><td> cimetidine possibly enhances myelosuppressive effects of carmustine </td><td></td></tr><tr><td><a href="41001i335.htm" name="_335">Chloroquine and Hydroxychloroquine</a></td><td> cimetidine inhibits metabolism of chloroquine and hydroxychloroquine (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i374.htm" name="_374">Chlorpromazine</a></td><td> cimetidine possibly enhances effects of chlorpromazine </td><td></td></tr><tr><td><a href="41001i499.htm" name="_499">Ciclosporin</a></td><td class="cBV"><b> cimetidine possibly increases plasma concentration of ciclosporin </b></td><td></td></tr><tr><td><a href="41001i233.htm" name="_233">Citalopram</a></td><td> cimetidine increases plasma concentration of citalopram </td><td></td></tr><tr><td><a href="41001i423.htm" name="_423">Clomethiazole</a></td><td> cimetidine inhibits metabolism of clomethiazole (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i865.htm" name="_865">Clopidogrel</a></td><td class="cBV"><b> cimetidine possibly reduces antiplatelet effect of clopidogrel </b></td><td></td></tr><tr><td><a href="41001i364.htm" name="_364">Clozapine</a></td><td> cimetidine possibly enhances effects of clozapine </td><td>Avoid concomitant use of clozapine with drugs that have a substantial potential for causing agranulocytosis</td></tr><tr><td><a href="41001i220.htm" name="_220">Coumarins</a></td><td class="cBV"><b> cimetidine inhibits metabolism of coumarins (enhanced anticoagulant effect)</b></td><td>Change in patient’s clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</td></tr><tr><td><a href="41001i246.htm" name="_246">Doxepin</a></td><td> cimetidine inhibits metabolism of doxepin (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i1030.htm" name="_1030">Epirubicin</a></td><td class="cBV"><b> cimetidine increases plasma concentration of epirubicin </b></td><td></td></tr><tr><td><a href="41001i563.htm" name="_563">Ergotamine and Methysergide</a></td><td class="cBV"><b>increased risk of ergotism when  cimetidine given with ergotamine and methysergide—avoid concomitant use</b></td><td></td></tr><tr><td><a href="41001i1048.htm" name="_1048">Erlotinib</a></td><td class="cBV"><b>avoidance of  cimetidine advised by manufacturer of erlotinib </b></td><td></td></tr><tr><td><a href="41001i169.htm" name="_169">Erythromycin</a></td><td> cimetidine increases plasma concentration of erythromycin (increased risk of toxicity, including deafness)</td><td>Interactions do not apply to small amounts of erythromycin used topically</td></tr><tr><td><a href="41001i964.htm" name="_964">Escitalopram</a></td><td> cimetidine increases plasma concentration of escitalopram </td><td></td></tr><tr><td><a href="41001i1220.htm" name="_1220">Fampridine</a></td><td class="cBV"><b>avoidance of  cimetidine advised by manufacturer of fampridine </b></td><td></td></tr><tr><td><a href="41001i120.htm" name="_120">Flecainide</a></td><td> cimetidine inhibits metabolism of flecainide (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i509.htm" name="_509">Fluorouracil</a></td><td> cimetidine inhibits metabolism of fluorouracil (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i247.htm" name="_247">Imipramine</a></td><td> cimetidine inhibits metabolism of imipramine (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i472.htm" name="_472">Isradipine</a></td><td> cimetidine increases plasma concentration of isradipine (halve dose of isradipine)</td><td></td></tr><tr><td><a href="41001i448.htm" name="_448">Labetalol</a></td><td> cimetidine increases plasma concentration of labetalol </td><td></td></tr><tr><td><a href="41001i738.htm" name="_738">Levothyroxine</a></td><td> cimetidine reduces absorption of levothyroxine </td><td></td></tr><tr><td><a href="41001i55.htm" name="_55">Lidocaine</a></td><td class="cBV"><b> cimetidine increases plasma concentration of lidocaine (increased risk of toxicity)</b></td><td>Interactions less likely when lidocaine used topically</td></tr><tr><td><a href="41001i1122.htm" name="_1122">Lomustine</a></td><td> cimetidine possibly enhances myelosuppressive effects of lomustine </td><td></td></tr><tr><td><a href="41001i309.htm">Loratadine</a></td><td>manufacturer of loratadine advises  cimetidine possibly increases plasma concentration of loratadine </td><td></td></tr><tr><td><a href="41001i609.htm" name="_609">Mebendazole</a></td><td> cimetidine possibly inhibits metabolism of mebendazole (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i1114.htm" name="_1114">Melatonin</a></td><td> cimetidine increases plasma concentration of melatonin </td><td></td></tr><tr><td><a href="41001i267.htm" name="_267">Metformin</a></td><td> cimetidine reduces excretion of metformin (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i451.htm" name="_451">Metoprolol</a></td><td> cimetidine increases plasma concentration of metoprolol </td><td></td></tr><tr><td><a href="41001i170.htm" name="_170">Metronidazole</a></td><td> cimetidine inhibits metabolism of metronidazole (increased plasma concentration)</td><td>Interactions do not apply to topical metronidazole preparations </td></tr><tr><td><a href="41001i823.htm" name="_823">Mirtazapine</a></td><td> cimetidine increases plasma concentration of mirtazapine </td><td></td></tr><tr><td><a href="41001i262.htm" name="_262">Moclobemide</a></td><td> cimetidine increases plasma concentration of moclobemide (halve dose of moclobemide)</td><td></td></tr><tr><td><a href="41001i249.htm" name="_249">Nortriptyline</a></td><td> cimetidine inhibits metabolism of nortriptyline (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i584.htm">Octreotide</a></td><td>absorption of  cimetidine possibly delayed by octreotide </td><td></td></tr><tr><td><a href="41001i85.htm" name="_85">Opioid Analgesics</a></td><td> cimetidine inhibits metabolism of opioid analgesics (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i284.htm" name="_284">Phenytoin</a></td><td class="cBV"><b> cimetidine inhibits metabolism of phenytoin (increased plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i1060.htm" name="_1060">Posaconazole</a></td><td class="cBV"><b> cimetidine reduces plasma concentration of posaconazole </b></td><td></td></tr><tr><td><a href="41001i881.htm" name="_881">Pramipexole</a></td><td> cimetidine reduces excretion of pramipexole (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i125.htm" name="_125">Propafenone</a></td><td class="cBV"><b> cimetidine increases plasma concentration of propafenone </b></td><td></td></tr><tr><td><a href="41001i793.htm" name="_793">Propranolol</a></td><td> cimetidine increases plasma concentration of propranolol </td><td></td></tr><tr><td><a href="41001i341.htm" name="_341">Quinine</a></td><td> cimetidine inhibits metabolism of quinine (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i201.htm" name="_201">Rifampicin</a></td><td>metabolism of  cimetidine accelerated by rifampicin (reduced plasma concentration)</td><td></td></tr><tr><td><a href="41001i1190.htm" name="_1190">Roflumilast</a></td><td> cimetidine inhibits the metabolism of roflumilast </td><td></td></tr><tr><td><a href="41001i791.htm" name="_791">Saquinavir</a></td><td> cimetidine possibly increases plasma concentration of saquinavir </td><td></td></tr><tr><td><a href="41001i237.htm" name="_237">Sertraline</a></td><td> cimetidine increases plasma concentration of sertraline </td><td></td></tr><tr><td><a href="41001i858.htm" name="_858">Sildenafil</a></td><td> cimetidine increases plasma concentration of sildenafil (consider reducing dose of sildenafil)</td><td></td></tr><tr><td><a href="41001i268.htm" name="_268">Sulfonylureas</a></td><td> cimetidine enhances hypoglycaemic effect of sulfonylureas </td><td></td></tr><tr><td><a href="41001i292.htm" name="_292">Terbinafine</a></td><td> cimetidine increases plasma concentration of terbinafine </td><td></td></tr><tr><td><a href="41001i734.htm" name="_734">Theophylline</a></td><td class="cBV"><b> cimetidine inhibits metabolism of theophylline (increased plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i1027.htm" name="_1027">Tolazoline</a></td><td class="cBV"><b> cimetidine antagonises effects of tolazoline </b></td><td></td></tr><tr><td><a href="41001i286.htm" name="_286">Valproate</a></td><td class="cBV"><b> cimetidine inhibits metabolism of valproate (increased plasma concentration)</b></td><td></td></tr><tr><td><a href="41001i904.htm" name="_904">Zaleplon</a></td><td> cimetidine inhibits metabolism of zaleplon (increased plasma concentration)</td><td></td></tr><tr><td><a href="41001i575.htm" name="_575">Zolmitriptan</a></td><td> cimetidine inhibits metabolism of zolmitriptan (reduce dose of zolmitriptan)</td><td></td></tr></tbody></table><p>Cimetidine belongs to <b>Histamine H<sub>2</sub>-antagonists</b>
          and will have the following interactions:
        </p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cBT" /><col width="40%" class="cBS" /><col width="30%" class="cBU" /></colgroup><tbody>









<tr><td><a href="41001i1005.htm">Atazanavir</a></td><td class="cBV"><b> histamine H<sub>2</sub>-antagonists reduce plasma concentration of atazanavir </b></td><td></td></tr><tr><td><a href="41001i148.htm">Cefpodoxime</a></td><td> histamine H<sub>2</sub>-antagonists reduce absorption of cefpodoxime </td><td></td></tr><tr><td><a href="41001i1180.htm">Histamine</a></td><td> histamine H<sub>2</sub>-antagonists theoretically antagonise effects of histamine—manufacturer of histamine advises avoid concomitant use</td><td></td></tr><tr><td><a href="41001i302.htm">Itraconazole</a></td><td> histamine H<sub>2</sub>-antagonists reduce absorption of itraconazole </td><td></td></tr><tr><td><a href="41001i298.htm">Ketoconazole</a></td><td> histamine H<sub>2</sub>-antagonists reduce absorption of ketoconazole </td><td></td></tr><tr><td><a href="41001i1128.htm">Lapatinib</a></td><td> histamine H<sub>2</sub>-antagonists possibly reduce absorption of lapatinib </td><td></td></tr><tr><td><a href="41001i1060.htm">Posaconazole</a></td><td>avoidance of  histamine H<sub>2</sub>-antagonists advised by manufacturer of posaconazole (plasma concentration of posaconazole possibly reduced)</td><td></td></tr><tr><td><a href="41001i1111.htm">Raltegravir</a></td><td> histamine H<sub>2</sub>-antagonists possibly increase plasma concentration of raltegravir—manufacturer of raltegravir advises avoid concomitant use</td><td></td></tr><tr><td><a href="41001i1163.htm">Ulipristal</a></td><td class="cBV"><b>avoidance of  histamine H<sub>2</sub>-antagonists advised by manufacturer of ulipristal (plasma concentration of ulipristal possibly reduced)</b></td><td></td></tr></tbody></table><p>Cimetidine belongs to <b>Ulcer-healing Drugs</b>
          but <b>Ulcer-healing Drugs</b>
          has no interactions information.
        </p></div><?highlighter on?><?highlighter off?><div id="pE">◄ <a accesskey="[" href="41001i743.htm">Previous: Histamine H<sub>2</sub>-antagonists</a> | <a class="top" href="41001i744.htm#">Top</a> | <a accesskey="]" href="41001i745.htm">Next: Famotidine</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>